| Literature DB >> 26421308 |
Mahnaz Etehad Tavakol1, Alimohammad Fatemi2, Abdolamir Karbalaie3, Zahra Emrani1, Björn-Erik Erlandsson3.
Abstract
Video nailfold capillaroscopy (NFC), considered as an extension of the widefield technique, allows a more accurate measuring and storing of capillary data and a better defining, analyzing, and quantifying of capillary abnormalities. Capillaroscopic study is often performed on the patients suspected of having microcirculation problems such as Raynaud's phenomenon as the main indication for nailfold capillaroscopy. Capillaroscopic findings based on microcirculation studies can provide useful information in the fields of pathophysiology, differential diagnosis, and monitoring therapy. Nailfold capillaroscopy provides a vital assessment in clinical practices and research; for example, its reputation in the early diagnosis of systemic sclerosis is well established and it is also used as a classification criterion in this regard. This review focuses on the manner of performing video nailfold capillaroscopy and on a common approach for measuring capillary dimensions in fingers and toes.Entities:
Mesh:
Year: 2015 PMID: 26421308 PMCID: PMC4569783 DOI: 10.1155/2015/974530
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Various steps required for a nailfold capillaroscopy procedure.
Figure 2Panoramic mosaic image at 200x magnification.
Figure 3(a) Measurement of capillary density by the direct observation method and (b) measurement of capillary density by the 90° method.
Capillary density scoring systems.
| Reference | Points | Capillary density per mm | |
|---|---|---|---|
|
Lefford and Edwards [ | 0 | >9 | |
| 1 | >7–9 | ||
| 2 | >4–7 | ||
| 3 | ⩽4 | ||
|
| |||
| Cutolo and Smith [ | 0 | More than 9 capillaries | |
| 1 | <33% reduction of capillaries (7–9 capillaries) | ||
| 2 | 33–66% reduction of capillaries (4–6 capillaries) | ||
| 3 | >66% reduction of capillaries (1–3 capillaries) | ||
|
| |||
| Reference | Points | Age ⩽ 40 years | Age > 40 years |
|
| |||
| Hoerth et al. [ | 0 | >7.75 | >8.5 |
| 1 | >7.25–7.75 | >7.75–8.5 | |
| 2 | >6–7.25 | >6–7.75 | |
| 3 | ⩽6 | ⩽6 | |
Figure 4Schematic drawing of the front portion of a nailfold capillary loop.
Figure 6(a, b) Two different images acquired by a digital capillaroscope with 200x magnification from two young healthy females to extract the features of capillaries marked with arrows. (c, d) Automated measuring of capillary width and height (PCA method). (e, f) Manual measuring of capillary width and height.
Dimensions of capillary parameters reported for healthy adults.
| Study (year, country) | Number of | Capillary | Intercapillary | Loop | Internal | Capillary | Apex | Venous | Arterial | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| Lefford and Edwards (1986, England) | 18 | 146.3 ± 54.7 | 142.2 ± 26.0 | 39.8 ± 9.6 | 34.3 ± 8.9 | 10.9 ± 2.7 | [ | |||
| Grassi et al. (1992, Italy) | 25 | 23.3 ± 51.9 | 35.4 ± 9.4 | 38.1 ± 9.4 | 12.0 ± 3.0 | [ | ||||
| Kabasakal et al., (1996, England) | 38 | 215 ± 40 | [ | |||||||
| Bukhari et al. (1996, England) | 10 | 14 | 18 | 36 | 11 | 7 | [ | |||
| Schiavon et al. (1999, Italy) | 26 | 255 ± 24 | 118 ± 22 | [ | ||||||
| Chin et al. (1999, Taiwan) | 34 | [ | ||||||||
| Bhushan et al. (2000, England) | 44 | 15.2 ± 3.5 | 13.6 ± 2.6 | 11.3 ± 2.3 | [ | |||||
| Bukhari et al. (2000, England) | 20 | 17.2 | 42.7 | 15.6 | 13 | [ | ||||
| Lambova and Müller-Ladner | 34 | 197 ± 70 | 18 ± 1 | 13 ± 1 | [ | |||||
| Hofstee et al. (2013, Netherlands) | 14 | 17.40 ± 4.16 | 45.56 ± 8.79 | 15.95 ± 4.08 | 13.60 ± 2.74 | [ | ||||
| Graceffa et al. (2013, Italy) | 30 | 26.4 ± 5 | 46.1 ± 10 | 17.5 ± 3.1 | 14 ± 3.2 | [ | ||||
| Ingegnoli et al. (2013, Italy) | 100 | 237 | 153.5 | 18 | 21 | 41 | [ | |||
| Le and Cho (2014, Korea) | 25 | 270 ± 35 | 10 ± 2 | 32 ± 5 | [ |
Figure 5Enlarged capillary loops; (A) normal capillary loop, (B) enlarged afferent capillary loop, (C) enlarged efferent capillary loop, (D) enlarged apical capillary loop, and (E) horseshoe shape giant capillary loop.
Enlarged capillary scoring system.
| Reference | Points | Enlarged capillary |
|---|---|---|
| Koenig et al. [ | 0 | Normal |
| 1 | Borderline (<2 times the normal diameter) | |
| 2 | Definitely enlarged (⩽2 times, but ⩽4 times the normal diameter) | |
| 3 | Extremely enlarged (>4 times the normal diameter) | |
|
| ||
| Dinç et al. [ | 0 | Absent |
| 1 | Presence of focal enlarged capillaries or frequent presence of apically enlarged capillaries | |
| 2 | Frequent presence of enlarged capillaries or presence of giant capillaries | |
Capillary length and width scoring systems.
| Reference | Points | Length of capillary loops per mm |
|---|---|---|
| Redisch et al. [ | 0 | Normal (<300 μm) |
| 1 | Slightly elongated | |
| 2 | Moderately elongated | |
| 3 | Markedly elongated | |
|
| ||
| Reference | Points | Capillary width per mm |
|
| ||
| Lee et al. [ | 0 | Normal (<25 to 50 |
| 1 | Normal (<25 to 50 μm) | |
| 2 | Definitely widened (90 to 150 μm) | |
| 3 | Giant capillaries (>150 μm) | |
Figure 7(A) Manual measuring of the intercapillary distance and (B) automated measuring of the intercapillary distance.
Intercapillary distance scoring system.
| Reference | Points | Intercapillary distance per mm |
|---|---|---|
| Lefford and Edwards [ | 0 | Normal (<110 μm) |
| 1 | Slightly increased | |
| 2 | Definitely increased | |
| 3 | Markedly increased (>190 μm) |
Scoring systems for avascular areas.
| Reference | Points | Avascularity per mm |
|---|---|---|
| Cutolo et al. [ | 0 | No avascular areas |
| Terreri et al. [ | 1 | Mild (1 to 2 avascular areas) |
| Kabasakal et al. [ | 2 | Moderate loss of capillaries (>2 avascular areas) |
| Ingegnoli et al. [ | 3 | Severe (large and confluent avascular areas) |
|
| ||
| Anders et al. [ | 1 | Less than 1 to 3 capillaries |
| 2 | 4 to 6 capillaries | |
| 3 | More than 6 capillaries | |
|
| ||
| Hofstee et al. [ | 1 | None (loss of 2 or more consecutive capillaries) |
| 2 | Moderate (loss of 2 to 4 consecutive capillaries) | |
| 3 | Severe (loss of >4 consecutive capillaries, or >2 areas with loss of >2 capillaries) | |
Figure 8Distribution of capillary per mm; (a) normal capillary arrangement, (b) capillary disarrangement, (c) avascular areas (local paucity), and (d) an enlarged capillary and avascular areas [77].
Capillary distribution scoring systems.
| Reference | Points | Capillary distribution per mm |
|---|---|---|
| Cheng et al. [ | Stage A | |
| 0 | Regular (100%) | |
| 1 | Slight irregularity | |
| Stage B | ||
| 2 | Disarranged (<50%) | |
| 3 | Disarranged (>50%) | |
| Stage C | ||
| 4 | Local paucity | |
| 5 | Enlarged loop bordering local paucity | |
| 6 | Complete paucity | |
|
| ||
| Cutolo et al. [ | 0 | Normal distribution (no changes) |
| 1 | Mild disorganization (>33% alterations/mm) | |
| 2 | Moderate, disorganization (33 to 66% alterations/mm) | |
| 3 | Severe disorganization (>66% alterations/mm) | |
|
| ||
| Hofstee et al. [ | 0 | Normal (if there was a regular or slightly disturbed nailfold pattern) |
| 1 | Moderate | |
| 2 | Severe | |
Nailfold capillaroscopy patterns scoring system.
| Study | Patterns | Description |
|---|---|---|
| Ingegnoli et al. [ | Normal | 6–8 capillaries/mm, capillaries length between 200 and 500 |
| Minor | 6–8 capillaries/mm, <10% of the total loops can be longer than normal, and <50% can be tortuous loops, arranged in parallel rows, with the absence of hemorrhages | |
| Major | ⩽6–8 capillaries/mm, >10% of the total loops can be longer than normal, and >50% can be tortuous, enlarged, meandering, and branched loops, disarranged, with the presence of hemorrhages | |
| Scleroderma | <6 capillaries/mm, >10% of the total loops can be longer than normal, tortuous, branched, bushy, enlarged, and giant loops, disarranged, with presence of hemorrhages | |
|
| ||
| Pavlov-Dolijanovic et al. [ | Normal | Typical hair pin structure or minor capillary morphological changes in distribution or size of loops |
| Nonspecific | Meandering and crossed capillaries, capillary thinning, linear elongation of the loop, focal distribution of capillary hemorrhages, prominent subpapillary plexus, capillary spasm, nonhomogeneous distribution or size of loops, widening of the afferent, and apical and efferent part of loop | |
| Scleroderma [ |
| |
|
| ||
|
| ||
Figure 9Automated PCA method for measuring the capillary orientation [65].
Scoring system for subpapillary venous plexus visibility.
| Reference | Points | Subpapillary plexus visualization |
|---|---|---|
| Wertheimer and Werthelmer [ | 0 | Absence of plexus visibility; capillaries only are seen |
| 1 | Doubtful visibility or the occasional presence of a venule parallel to the nailfold | |
| 2 | Plexus visible only in restricted areas or throughout the width of the finger but only close to the distal row of capillaries | |
| 3 | Plexus visible throughout the width of the finger but not extending proximally, or if extending proximally, not generalized throughout the width of the finger | |
| 4 | Plexus visible throughout the width of the finger and proximally | |
|
| ||
| Kabasakal et al. [ | 0 | Not visible |
| 1 | Doubtful visibility | |
| 2 | Plexus visible only in restricted areas | |
| 3 | Prominently visible over a wide area | |